Acumen Pharmaceuticals Is Maintained at Buy by Citigroup
Ratings actions from Benzinga: GMT) Acumen Pharmaceuticals Price Target Raised to $5.00/Share From $4.00 by CitigroupRatings actions from Benzinga
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.